Advertisement


Lori Wiener, PhD, DCSW, LCSW-C, and Paul B. Jacobsen, PhD, on IPOS-APOS Themes of This Year’s Meeting

2015 IPOS APOS World Congress of Psycho-Oncology

Advertisement

Lori Wiener, PhD, DCSW, LCSW-C, of the National Cancer Institute, and Paul B. Jacobsen, PhD, of the Moffitt Cancer Center, discuss the highlights of this year’s meeting, which for the first time brings together the international and American psychosocial oncology societies.



Related Videos

Supportive Care

Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Adapting Meaning-Centered Psychotherapy for Caregivers

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, explain how they brought this new treatment to help stressed caregivers of loved ones with cancer.

Palliative Care
Global Cancer Care

Irene Higginson, MD, on Palliative and End-of-Life Care: An International Perspective

Irene Higginson, MD, of Cicely Saunders International, discusses the goals of psychosocial palliative care for patients around the world with advanced cancer.

Supportive Care
Survivorship

Julia H. Rowland, PhD, on The Psychosocial Challenges Cancer Survivors Face

Julia H. Rowland, PhD, of the National Cancer Institute, discusses the growing number of promising interventions to improve health and function for those living with and beyond a cancer diagnosis, as well as those who care for and about them.

Supportive Care

Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Creating Meaning-Centered Psychotherapy for Cancer Patients

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss the early days of this new treatment for despair and distress in cancer patients.

Survivorship
Supportive Care
Prostate Cancer

Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis

Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory

Advertisement

Advertisement




Advertisement